{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:27:58Z","timestamp":1792481278836,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05987-0","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T11:29:55Z","timestamp":1758713395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Methotrexate and biological therapy are not associated with fatty liver in rheumatoid arthritis\u2014a cross-sectional study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-5394","authenticated-orcid":false,"given":"Tatjana","family":"Zeki\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6041-5668","authenticated-orcid":false,"given":"Filip","family":"Bla\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-9275","authenticated-orcid":false,"given":"Nata\u0161a","family":"Katalini\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-0237","authenticated-orcid":false,"given":"Nada Star\u010devi\u0107","family":"\u010cizmarevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1590-0450","authenticated-orcid":false,"given":"Aleksandar","family":"\u010cubrani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"Suppl","key":"5987_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH et al (2023) Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol 29(Suppl):S32\u2013S42. https:\/\/doi.org\/10.3350\/cmh.2022.0365","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"5987_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.semarthrit.2016.05.012","volume":"46","author":"LC Coates","year":"2016","unstructured":"Coates LC, FitzGerald O, Helliwell PS, Paul C (2016) Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same? Semin Arthritis Rheum 46(3):291\u2013304. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.05.012","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"5987_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W et al (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disorders 22(1):63. https:\/\/doi.org\/10.1186\/s12902-022-00980-1","journal-title":"BMC Endocr Disorders"},{"issue":"3","key":"5987_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the Liver","year":"2021","unstructured":"European Association for the Study of the Liver (2021) EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013\u20092021 update. J Hepatol 75(3):659\u2013689. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.025","journal-title":"J Hepatol"},{"key":"5987_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cca.2016.02.010","volume":"455","author":"S Mateen","year":"2016","unstructured":"Mateen S, Zafar A, Moin S, Khan AQ, Zubair S (2016) Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta 455:161\u2013171. https:\/\/doi.org\/10.1016\/j.cca.2016.02.010","journal-title":"Clin Chim Acta"},{"key":"5987_CR6","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL et al (2022) Association of inflammatory cytokines with Non-Alcoholic fatty liver disease. Front Immunol 13:880298. https:\/\/doi.org\/10.3389\/fimmu.2022.880298","journal-title":"Front Immunol"},{"issue":"3","key":"5987_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.14218\/jcth.2021.00243","volume":"10","author":"N Hernandez","year":"2022","unstructured":"Hernandez N, Bessone F (2022) Hepatotoxicity induced by biological agents: clinical features and current controversies. J Clin Transl Hepatol 10(3):486\u2013495. https:\/\/doi.org\/10.14218\/jcth.2021.00243","journal-title":"J Clin Transl Hepatol"},{"key":"5987_CR8","doi-asserted-by":"publisher","unstructured":"Lopetuso LR, Mocci G, Marzo M, D\u2019Aversa F, Rapaccini GL, Guidi L et al (2018) Harmful effects and potential benefits of Anti-Tumor necrosis factor (TNF)-\u03b1 on the liver. Int J Mol Sci 19(8). https:\/\/doi.org\/10.3390\/ijms19082199","DOI":"10.3390\/ijms19082199"},{"key":"5987_CR9","doi-asserted-by":"publisher","first-page":"1759720x2412833","DOI":"10.1177\/1759720x241283340","volume":"16","author":"PC Taylor","year":"2024","unstructured":"Taylor PC, Feist E, Pope JE, Nash P, Sibilia J, Caporali R et al (2024) What have we learnt from the Inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes? Ther Adv Musculoskelet Dis 16:1759720x241283340. https:\/\/doi.org\/10.1177\/1759720x241283340","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"5987_CR10","first-page":"465","volume":"37","author":"S Casta\u00f1eda","year":"2019","unstructured":"Casta\u00f1eda S, Remuzgo-Mart\u00ednez S, L\u00f3pez-Mej\u00edas R, Genre F, Calvo-Al\u00e9n J, Llorente I et al (2019) Rapid beneficial effect of the IL-6 receptor Blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis. Clin Exp Rheumatol 37(3):465\u2013473","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"5987_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00296-022-05143-y","volume":"42","author":"T Zeki\u0107","year":"2022","unstructured":"Zeki\u0107 T, Beni\u0107 MS, Radi\u0107 M (2022) Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease. Rheumatol Int 42(10):1665\u20131679. https:\/\/doi.org\/10.1007\/s00296-022-05143-y","journal-title":"Rheumatol Int"},{"issue":"11","key":"5987_CR12","doi-asserted-by":"publisher","first-page":"102390","DOI":"10.1016\/j.autrev.2019.102390","volume":"18","author":"Y Jamilloux","year":"2019","unstructured":"Jamilloux Y, El Jammal T, Vuitton L, Gerfaud-Valentin M, Kerever S, S\u00e8ve P (2019) JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev 18(11):102390. https:\/\/doi.org\/10.1016\/j.autrev.2019.102390","journal-title":"Autoimmun Rev"},{"issue":"10","key":"5987_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","volume":"23","author":"S Rose-John","year":"2023","unstructured":"Rose-John S, Jenkins BJ, Garbers C, Moll JM, Scheller J (2023) Targeting IL-6 trans-signalling: past, present and future prospects. Nat Rev Immunol 23(10):666\u2013681. https:\/\/doi.org\/10.1038\/s41577-023-00856-y","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"5987_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1242\/dmm.019166","volume":"8","author":"M Vida","year":"2015","unstructured":"Vida M, Gavito AL, Pavon FJ, Bautista D, Serrano A, Suarez J et al (2015) Chronic administration of Recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice. Dis Model Mech 8(7):721\u2013731. https:\/\/doi.org\/10.1242\/dmm.019166","journal-title":"Dis Model Mech"},{"key":"5987_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2147\/JIR.S395137","volume":"16","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhang C, An Y, Zhang Z, Zhao J, Zhang X et al (2023) Research on liver damage caused by the treatment of rheumatoid arthritis with novel biological agents or targeted agents. J Inflamm Res 16:443\u2013452. https:\/\/doi.org\/10.2147\/JIR.S395137","journal-title":"J Inflamm Res"},{"issue":"9","key":"5987_CR16","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al (2010) 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/european league against rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5987_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhep.2010.06.022","volume":"54","author":"S Gaia","year":"2011","unstructured":"Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F et al (2011) Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 54(1):64\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2010.06.022","journal-title":"J Hepatol"},{"issue":"2","key":"5987_CR18","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6(2):65\u201370","journal-title":"Scand J Stat"},{"issue":"5","key":"5987_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.5114\/aoms\/152921","volume":"18","author":"P Dobrowolski","year":"2022","unstructured":"Dobrowolski P, Prejbisz A, Kurylowicz A, Baska A, Burchardt P, Chlebus K et al (2022) Metabolic syndrome - a new definition and management guidelines: A joint position paper by the Polish society of hypertension, Polish society for the treatment of obesity, Polish lipid association, Polish association for study of liver, Polish society of family medicine, Polish society of lifestyle medicine, division of prevention and epidemiology Polish cardiac society, club 30 Polish cardiac society, and division of metabolic and bariatric surgery society of Polish surgeons. Arch Med Sci 18(5):1133\u20131156. https:\/\/doi.org\/10.5114\/aoms\/152921","journal-title":"Arch Med Sci"},{"issue":"11","key":"5987_CR20","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1016\/j.cgh.2023.02.021","volume":"21","author":"M Zamani","year":"2023","unstructured":"Zamani M, Alizadeh-Tabari S, Chitkara P, Singh S, Loomba R (2023) Prevalence of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A systematic review and Meta-analysis. Clin Gastroenterol Hepatol 21(11):2789\u20132796. https:\/\/doi.org\/10.1016\/j.cgh.2023.02.021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"5987_CR21","doi-asserted-by":"publisher","first-page":"e0170361","DOI":"10.1371\/journal.pone.0170361","volume":"12","author":"J Hallajzadeh","year":"2017","unstructured":"Hallajzadeh J, Safiri S, Mansournia MA, Khoramdad M, Izadi N, Almasi-Hashiani A et al (2017) Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis. PLoS ONE 12(3):e0170361. https:\/\/doi.org\/10.1371\/journal.pone.0170361","journal-title":"PLoS ONE"},{"issue":"1","key":"5987_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5606\/ArchRheumatol.2017.5949","volume":"32","author":"PK Pandey","year":"2017","unstructured":"Pandey PK, Swami A, Biswas TK, Thakuria R (2017) Prevalence of metabolic syndrome in treatment Naive rheumatoid arthritis and correlation with disease parameters. Arch Rheumatol 32(1):46\u201352. https:\/\/doi.org\/10.5606\/ArchRheumatol.2017.5949","journal-title":"Arch Rheumatol"},{"issue":"3","key":"5987_CR23","doi-asserted-by":"publisher","first-page":"e23666","DOI":"10.1002\/jcla.23666","volume":"35","author":"M Garcia-Chagollan","year":"2021","unstructured":"Garcia-Chagollan M, Hernandez-Martinez SE, Rojas-Romero AE, Munoz-Valle JF, Sigala-Arellano R, Cerpa-Cruz S et al (2021) Metabolic syndrome in rheumatoid arthritis patients: relationship among its clinical components. J Clin Lab Anal 35(3):e23666. https:\/\/doi.org\/10.1002\/jcla.23666","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"5987_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4021\/jocmr1001w","volume":"4","author":"M Karakoc","year":"2012","unstructured":"Karakoc M, Batmaz I, Sariyildiz MA, Tahtasiz M, Cevik R, Tekbas E et al (2012) The relationship of metabolic syndrome with disease activity and the functional status in patients with rheumatoid arthritis. J Clin Med Res 4(4):279\u2013285. https:\/\/doi.org\/10.4021\/jocmr1001w","journal-title":"J Clin Med Res"},{"issue":"1","key":"5987_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s42358-019-0089-1","volume":"59","author":"MFB de Resende Guimar\u00e3es","year":"2019","unstructured":"de Resende Guimar\u00e3es MFB, Rodrigues CEM, Gomes KWP, Machado CJ, Brenol CV, Krampe SF et al (2019) High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study. Adv Rheumatol 59(1):44. https:\/\/doi.org\/10.1186\/s42358-019-0089-1","journal-title":"Adv Rheumatol"},{"issue":"11","key":"5987_CR26","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41591-021-01501-8","volume":"27","author":"Q Li","year":"2021","unstructured":"Li Q, Hagberg CE, Silva Cascales H, Lang S, Hyvonen MT, Salehzadeh F et al (2021) Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce. Nat Med 27(11):1941\u20131953. https:\/\/doi.org\/10.1038\/s41591-021-01501-8","journal-title":"Nat Med"},{"key":"5987_CR27","doi-asserted-by":"crossref","unstructured":"Rafaqat S, Gluscevic S, Mercantepe F, Rafaqat S, Klisic A (2024) Interleukins: pathogenesis in Non-Alcoholic fatty liver disease, vol 14. Metabolites, 310.3390\/metabo14030153","DOI":"10.3390\/metabo14030153"},{"issue":"2","key":"5987_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/acr.22932","volume":"69","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C (2017) Impact of obesity on remission and disease activity in rheumatoid arthritis: A systematic review and Meta-Analysis. Arthritis Care Res (Hoboken) 69(2):157\u2013165. https:\/\/doi.org\/10.1002\/acr.22932","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5987_CR29","doi-asserted-by":"publisher","unstructured":"Monteiro R, Azevedo I (2010) Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm 2010. https:\/\/doi.org\/10.1155\/2010\/289645","DOI":"10.1155\/2010\/289645"},{"issue":"7","key":"5987_CR30","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","volume":"21","author":"A Tang","year":"2023","unstructured":"Tang A, Ng CH, Phang PH, Chan KE, Chin YH, Fu CE et al (2023) Comparative burden of metabolic dysfunction in lean NAFLD vs Non-lean NAFLD - A systematic review and Meta-analysis. Clin Gastroenterol Hepatol 21(7):1750\u20131760e12. https:\/\/doi.org\/10.1016\/j.cgh.2022.06.029","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"5987_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1530\/eje.0.1480535","volume":"148","author":"JM Bruun","year":"2003","unstructured":"Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B (2003) Association between measures of insulin sensitivity and Circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 148(5):535\u2013542. https:\/\/doi.org\/10.1530\/eje.0.1480535","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"5987_CR32","doi-asserted-by":"publisher","first-page":"e15003","DOI":"10.1111\/1756-185X.15003","volume":"27","author":"CC Meng","year":"2024","unstructured":"Meng CC, Chen DY, Chen YH, Huang WN, Chen HH (2024) Antirheumatic drugs and the risk of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A nationwide, population-based cohort study. Int J Rheum Dis 27(1):e15003. https:\/\/doi.org\/10.1111\/1756-185X.15003","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"5987_CR33","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s10067-020-05456-y","volume":"40","author":"Y Choi","year":"2021","unstructured":"Choi Y, Lee CH, Kim IH, Park EH, Park S, Yoo WH (2021) Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study. Clin Rheumatol 40(5):2037\u20132045. https:\/\/doi.org\/10.1007\/s10067-020-05456-y","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5987_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/1756-185X.13442","volume":"22","author":"R Lertnawapan","year":"2019","unstructured":"Lertnawapan R, Chonprasertsuk S, Siramolpiwat S (2019) Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by fibroscan in rheumatoid arthritis patients receiving methotrexate. Int J Rheum Dis 22(2):214\u2013221. https:\/\/doi.org\/10.1111\/1756-185X.13442","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"5987_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.aohep.2019.01.011","volume":"18","author":"DS Garc\u00eda","year":"2019","unstructured":"Garc\u00eda DS, Saturansky EI, Poncino D, Mart\u00ednez-Artola Y, Rosenberg S, Abritta G, Ascimani-Pe\u00f1a C, Cravero A (2019) Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency? Ann Hepatol 18(5):765\u2013769. https:\/\/doi.org\/10.1016\/j.aohep.2019.01.011","journal-title":"Ann Hepatol"},{"key":"5987_CR36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00296-021-04804-8","volume":"41","author":"M Feuchtenberger","year":"2021","unstructured":"Feuchtenberger M, Kraus L, Nigg A et al (2021) Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study). Rheumatol Int 41:1079\u20131087. https:\/\/doi.org\/10.1007\/s00296-021-04804-8","journal-title":"Rheumatol Int"},{"issue":"8","key":"5987_CR37","doi-asserted-by":"publisher","first-page":"e0203084","DOI":"10.1371\/journal.pone.0203084","volume":"13","author":"S Mori","year":"2018","unstructured":"Mori S, Arima N, Ito M, Fujiyama S, Kamo Y, Ueki Y (2018) Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment. PLoS ONE 13(8):e0203084. https:\/\/doi.org\/10.1371\/journal.pone.0203084","journal-title":"PLoS ONE"},{"issue":"7","key":"5987_CR38","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1136\/jim-2021-002206","volume":"70","author":"HI Cheema","year":"2022","unstructured":"Cheema HI, Haselow D, Dranoff JA (2022) Review of existing evidence demonstrates that methotrexate does not cause liver fibrosis. J Investig Med 70(7):1452\u20131460. https:\/\/doi.org\/10.1136\/jim-2021-002206","journal-title":"J Investig Med"},{"issue":"10","key":"5987_CR39","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184(10):2537\u20132564. https:\/\/doi.org\/10.1016\/j.cell.2021.04.015","journal-title":"Cell"},{"key":"5987_CR40","doi-asserted-by":"publisher","first-page":"1759720x2110427","DOI":"10.1177\/1759720x211042739","volume":"13","author":"GL Erre","year":"2021","unstructured":"Erre GL, Castagna F, Sauchella A, Meloni P, Mangoni AA, Farina G et al (2021) Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case-control study. Ther Adv Musculoskelet Dis 13:1759720x211042739. https:\/\/doi.org\/10.1177\/1759720x211042739","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"5987_CR41","doi-asserted-by":"publisher","first-page":"e000349","DOI":"10.1136\/bmjgast-2019-000349","volume":"7","author":"KT Tang","year":"2020","unstructured":"Tang KT, Dufour JF, Chen PH, Hernaez R, Hutfless S (2020) Antitumour necrosis factor-alpha agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort. BMJ Open Gastroenterol 7(1):e000349. https:\/\/doi.org\/10.1136\/bmjgast-2019-000349","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"5987_CR42","doi-asserted-by":"publisher","first-page":"e079296","DOI":"10.1136\/bmjopen-2023-079296","volume":"14","author":"WL Ho","year":"2024","unstructured":"Ho WL, Chen HH, Chen PK, Liao TL, Chang SH, Chen YM et al (2024) Increased NAFLD risk in newly diagnosed patients with RA during the first 4 years of follow-up: a nationwide, population-based cohort study. BMJ Open 14(1):e079296. https:\/\/doi.org\/10.1136\/bmjopen-2023-079296","journal-title":"BMJ Open"},{"issue":"10","key":"5987_CR43","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","volume":"3","author":"JK Sethi","year":"2021","unstructured":"Sethi JK, Hotamisligil GS (2021) Metabolic messengers: tumour necrosis factor. Nat Metab 3(10):1302\u20131312. https:\/\/doi.org\/10.1038\/s42255-021-00470-z","journal-title":"Nat Metab"},{"issue":"3","key":"5987_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","volume":"12","author":"ID Vachliotis","year":"2023","unstructured":"Vachliotis ID, Polyzos SA (2023) The role of tumor necrosis Factor-Alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease. Curr Obes Rep 12(3):191\u2013206. https:\/\/doi.org\/10.1007\/s13679-023-00519-y","journal-title":"Curr Obes Rep"},{"issue":"11","key":"5987_CR45","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","volume":"18","author":"MD Giraldez","year":"2021","unstructured":"Giraldez MD, Carneros D, Garbers C, Rose-John S, Bustos M (2021) New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology. Nat Rev Gastroenterol Hepatol 18(11):787\u2013803. https:\/\/doi.org\/10.1038\/s41575-021-00473-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"5987_CR46","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2337\/db23-0171","volume":"72","author":"A Gunes","year":"2023","unstructured":"Gunes A, Schmitt C, Bilodeau L, Huet C, Belblidia A, Baldwin C et al (2023) IL-6 Trans-Signaling is increased in diabetes, impacted by glucolipotoxicity, and associated with liver stiffness and fibrosis in fatty liver disease. Diabetes 72(12):1820\u20131834. https:\/\/doi.org\/10.2337\/db23-0171","journal-title":"Diabetes"},{"key":"5987_CR47","doi-asserted-by":"publisher","unstructured":"Ulusan M, Erdogan MA, Simsek O, Dogan Z, Ciftci BB, Atalan G et al (2025) Baricitinib mitigates Methotrexate-Induced liver fibrosis model via YAP pathway. Medicina 61. https:\/\/doi.org\/10.3390\/medicina61050857","DOI":"10.3390\/medicina61050857"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05987-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:02:41Z","timestamp":1761588161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05987-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["5987"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05987-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Clinical Hospital Centre Rijeka Ethics Committee (Nr: 2170-29-02\/1-23-2; November 23 2023; Clinical Hospital Centre Rijeka, Kre\u0161imirova 42, HR-51000 Rijeka, Croatia).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"236"}}